Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2005-08-04

Original market date: See footnote 1

1999-06-28

Product name:

NOVOLINSET GE 30/70 INJ SUS

DIN:

02024446 Electronic product monograph is not available

Company:

NOVO NORDISK A/S
Novo Alle
Bagsvaerd
--
Denmark 2880

Class:

Human

Dosage form(s):

Suspension

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

2

Schedule(s):

Schedule D

 

American Hospital Formulary Service (AHFS): See footnote 3

68:20.08 

Anatomical Therapeutic Chemical (ATC): See footnote 4

A10AD01 INSULIN (HUMAN)

Active ingredient group (AIG) number:See footnote5

0223312003

List of active ingredient(s)
Active ingredient(s) Strength
INSULIN INJECTION HUMAN BIOSYNTHETIC 30 UNIT / ML
INSULIN ISOPHANE HUMAN BIOSYNTHETIC 70 UNIT / ML
Version 4.0.2
Date modified: